Related Experiment Videos

Cardiovascular risk factors in minorities

John C LaRosa1, Clinton D Brown

  • 1Office of the President, SUNY Downstate Medical Center, Brooklyn, NY 11203-2098, USA. jclarosa@downstate.edu

Insights

Interventions for hypertension and hyperlipidemia are vital for preventing atherosclerosis. However, risk factor prevalence and intervention effectiveness may differ in minority populations, necessitating further research.

Area of Science:

  • Cardiovascular Medicine
  • Public Health
  • Health Disparities

Background:

  • Atherosclerosis progression and clinical outcomes are influenced by major risk factors like hypertension and hyperlipidemia.
  • Limited data exists on the prevalence and impact of atherosclerosis risk factors within minority populations.
  • Minority inclusion in clinical trials is often insufficient to assess differential intervention benefits.

Purpose of the Study:

  • To review the prevalence of atherosclerosis risk factors in minority populations.
  • To assess the inclusion of minorities in clinical trials for cardiovascular risk factor intervention.
  • To highlight potential differences in risk factor profiles and intervention responses among diverse groups.

Main Methods:

  • Literature review of recent studies on atherosclerosis risk factors in minority populations.
  • Analysis of data on the prevalence of established and novel risk predictors.
  • Examination of minority participation rates in relevant clinical trials.

Main Results:

  • Significant variations in the prevalence of risk factors exist across different minority groups.
  • African descendants show higher rates of obesity, elevated blood pressure, and premature coronary death.
  • Certain Hispanic populations exhibit higher levels of triglycerides, low high-density lipoproteins, and diabetes compared to whites.
  • Minorities are underrepresented in clinical trials, limiting the assessment of intervention efficacy.

Conclusions:

  • Risk factor intervention is crucial for all populations, including minorities.
  • Differences in risk factor prevalence among minority groups warrant tailored approaches.
  • Further research is needed to determine if intervention responses vary qualitatively or quantitatively across different racial and ethnic groups.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Factors affecting Blood pressure01:28

Factors affecting Blood pressure

Several physiological and lifestyle factors influence blood pressure (BP). Understanding these factors is crucial as they are significant in patient education and blood pressure management.
Physiological Factors:
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...